OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?
Georgios K. Vasileiadis, Efthimios Dardiotis, Αthanasios Mavropoulos, et al.
Autoimmunity Highlights (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 43
Georgios K. Vasileiadis, Efthimios Dardiotis, Αthanasios Mavropoulos, et al.
Autoimmunity Highlights (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 43
Showing 26-50 of 43 citing articles:
Therapeutic intervention in relapsing autoimmune demyelinating disease through induction of myelin-specific regulatory CD8 T cell responses
Ashley A. Brate, Alexander W. Boyden, Farah R. Itani, et al.
Journal of Translational Autoimmunity (2019) Vol. 2, pp. 100010-100010
Open Access | Times Cited: 6
Ashley A. Brate, Alexander W. Boyden, Farah R. Itani, et al.
Journal of Translational Autoimmunity (2019) Vol. 2, pp. 100010-100010
Open Access | Times Cited: 6
Interleukin-10 production by B cells is regulated by cytokines, but independently of GATA-3 or FoxP3 expression
Pavla Boháčová, Jan Kössl, Michaela Hájková, et al.
Cellular Immunology (2019) Vol. 347, pp. 103987-103987
Closed Access | Times Cited: 6
Pavla Boháčová, Jan Kössl, Michaela Hájková, et al.
Cellular Immunology (2019) Vol. 347, pp. 103987-103987
Closed Access | Times Cited: 6
Enkephalin Therapy Improves Relapsing-Remitting Multiple Sclerosis
Chirag Patel, Ian S. Zagon, Gary A. Thomas, et al.
IntechOpen eBooks (2020)
Open Access | Times Cited: 5
Chirag Patel, Ian S. Zagon, Gary A. Thomas, et al.
IntechOpen eBooks (2020)
Open Access | Times Cited: 5
Multiple Sclerosis: Immune Cells, Histopathology, and Therapeutics
Manisha S. Patil, Linda Yingqi Lin, Felix Marsh‐Wakefield, et al.
Sclerosis (2024) Vol. 2, Iss. 3, pp. 117-139
Open Access
Manisha S. Patil, Linda Yingqi Lin, Felix Marsh‐Wakefield, et al.
Sclerosis (2024) Vol. 2, Iss. 3, pp. 117-139
Open Access
Joint Application of Magnetic Resonance Imaging and Biochemical Biomarkers in Diagnosis of Multiple Sclerosis
Fatemeh Momeni, A Ghaemmaghami, Majid Nejati, et al.
Current Medicinal Chemistry (2019) Vol. 27, Iss. 39, pp. 6703-6726
Closed Access | Times Cited: 3
Fatemeh Momeni, A Ghaemmaghami, Majid Nejati, et al.
Current Medicinal Chemistry (2019) Vol. 27, Iss. 39, pp. 6703-6726
Closed Access | Times Cited: 3
A companion to the preclinical common data elements and case report forms for neuropathology studies in epilepsy research. A report of the TASK3 WG2 Neuropathology Working Group of the ILAE /AES Joint Translational Task Force
Eleonora Aronica, Devin K. Binder, Meinrad Drexel, et al.
Epilepsia Open (2022)
Open Access | Times Cited: 2
Eleonora Aronica, Devin K. Binder, Meinrad Drexel, et al.
Epilepsia Open (2022)
Open Access | Times Cited: 2
Pathological and protective effects of tumor necrosis factor-alpha in multiple sclerosis
И. В. Смагина, S. A. Elchaninova, A. S. Palashchenko, et al.
S S Korsakov Journal of Neurology and Psychiatry (2019) Vol. 119, Iss. 10, pp. 14-14
Closed Access | Times Cited: 2
И. В. Смагина, S. A. Elchaninova, A. S. Palashchenko, et al.
S S Korsakov Journal of Neurology and Psychiatry (2019) Vol. 119, Iss. 10, pp. 14-14
Closed Access | Times Cited: 2
An Overview and Management of Multiple Chronic Conditions
Sevgi Akarsu
IntechOpen eBooks (2020)
Open Access | Times Cited: 2
Sevgi Akarsu
IntechOpen eBooks (2020)
Open Access | Times Cited: 2
B regulatory cells in patients with autoimmune diseases: Pathogenic significance and therapeutic potential
Αthanasios Mavropoulos, Efterpi Zafiriou, Efthimios Dardiotis, et al.
Elsevier eBooks (2022), pp. 37-53
Closed Access | Times Cited: 1
Αthanasios Mavropoulos, Efterpi Zafiriou, Efthimios Dardiotis, et al.
Elsevier eBooks (2022), pp. 37-53
Closed Access | Times Cited: 1
Possible biomarkers of therapy effective
Т. P. Оspelnikova, A. D. Shitova
Russian neurological Journal (2021) Vol. 26, Iss. 1, pp. 4-14
Open Access | Times Cited: 1
Т. P. Оspelnikova, A. D. Shitova
Russian neurological Journal (2021) Vol. 26, Iss. 1, pp. 4-14
Open Access | Times Cited: 1
PI3-Kinase p110α Deficiency Modulates T Cell Homeostasis and Function and Attenuates Experimental Allergic Encephalitis in Mature Mice
José María Rojo, María Montes‐Casado, Laura Aragoneses-Fenoll, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8698-8698
Open Access | Times Cited: 1
José María Rojo, María Montes‐Casado, Laura Aragoneses-Fenoll, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8698-8698
Open Access | Times Cited: 1
Novel contributors to B cell activation during inflammatory CNS demyelination; An oNGOing process
Olympia Damianidou, Paschalis Theotokis, Nikolaos Grigoriadis, et al.
International Journal of Medical Sciences (2021) Vol. 19, Iss. 1, pp. 164-174
Open Access | Times Cited: 1
Olympia Damianidou, Paschalis Theotokis, Nikolaos Grigoriadis, et al.
International Journal of Medical Sciences (2021) Vol. 19, Iss. 1, pp. 164-174
Open Access | Times Cited: 1
Anatomical Evaluation of The Corpus Callosum in Multiple Sclerosis Patients Using MRI
Hussam Alabdullah, Ece Mennan, Aslı Tanrıvermiş Sayit, et al.
Journal of Population Therapeutics and Clinical Pharmacology (2023) Vol. 30, Iss. 14
Open Access
Hussam Alabdullah, Ece Mennan, Aslı Tanrıvermiş Sayit, et al.
Journal of Population Therapeutics and Clinical Pharmacology (2023) Vol. 30, Iss. 14
Open Access
Targeting leukocytes in multiple sclerosis: Therapeutic perspectives
Danica Michaličková, Hatice Kübra Öztürk, Ondřej Slanař
Elsevier eBooks (2023), pp. 129-143
Closed Access
Danica Michaličková, Hatice Kübra Öztürk, Ondřej Slanař
Elsevier eBooks (2023), pp. 129-143
Closed Access
Drug Delivery Strategies for the Administration of Natural Compounds to the Brain in Neurodegenerative Diseases
Lorena Bonilla, Gerard Esteruelas, Miren Ettcheto, et al.
(2023), pp. 429-453
Closed Access
Lorena Bonilla, Gerard Esteruelas, Miren Ettcheto, et al.
(2023), pp. 429-453
Closed Access
Prooxidant-antioxidant balance in relapsing-remitting multiple sclerosis patients
Samaneh Sabouri, Daryoush Hamidi Alamdari, Sanaz Salaramoli, et al.
Medical Laboratory Journal (2023) Vol. 17, Iss. 4, pp. 20-23
Closed Access
Samaneh Sabouri, Daryoush Hamidi Alamdari, Sanaz Salaramoli, et al.
Medical Laboratory Journal (2023) Vol. 17, Iss. 4, pp. 20-23
Closed Access
Immunoglobulin G index as a biomarker of relapse response to corticosteroids during early stages of multiple sclerosis
Farouk Talaat, Ismael Ramadan, Eman Hamdy, et al.
Multiple Sclerosis and Related Disorders (2019) Vol. 38, pp. 101495-101495
Closed Access
Farouk Talaat, Ismael Ramadan, Eman Hamdy, et al.
Multiple Sclerosis and Related Disorders (2019) Vol. 38, pp. 101495-101495
Closed Access
Pathological and protective effects of tumor necrosis factor-alpha in multiple sclerosis
И. В. Смагина, S. A. Elchaninova, A. S. Palashchenko, et al.
S S Korsakov Journal of Neurology and Psychiatry (2019) Vol. 119, Iss. 10, pp. 14-14
Closed Access
И. В. Смагина, S. A. Elchaninova, A. S. Palashchenko, et al.
S S Korsakov Journal of Neurology and Psychiatry (2019) Vol. 119, Iss. 10, pp. 14-14
Closed Access
